• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Public health problems related to chemoprevention of cancers].

作者信息

Schaffer P, Allemand H

机构信息

Laboratoire d'épidémiologie et de santé publique, faculté de médecine, Strasbourg, France.

出版信息

Bull Cancer. 1995 Jul;82 Suppl 3:213s-223s.

PMID:7492835
Abstract

The chemoprevention sets down numbers of problems and requires certain number of conditions. First of all, one has to demonstrate the action's effectiveness by a randomised trial using the appropriate effectiveness indicators and to confirm the results of the trial by a pilot prevention's project. The action shouldn't have neither inconvenient nor major risks. In numerous prevention's action, the inconvenient are superior to the benefits. The action should be aware of respecting the major ethical aspects: respect the person's autonomy, don't to be harmful, respect the equity and be beneficial; it also has to avoid important psychological consequences. At last, the prevention's action has to appeal to cost effectiveness strategy.

摘要

相似文献

1
[Public health problems related to chemoprevention of cancers].
Bull Cancer. 1995 Jul;82 Suppl 3:213s-223s.
2
[Chemoprevention of cancers, the point of view of health insurance].[癌症的化学预防:医疗保险的视角]
Bull Cancer. 1995 Jul;82 Suppl 3:230s-231s.
3
[Medical chemoprevention of cancers. From the point of view of social sciences].[癌症的医学化学预防。从社会科学的角度来看]
Bull Cancer. 1995 Jul;82 Suppl 3:224s-229s.
4
[The precautionary principle: advantages and risks].[预防原则:优势与风险]
J Chir (Paris). 2001 Apr;138(2):68-80.
5
Use of modeling to evaluate the cost-effectiveness of cancer screening programs.运用建模方法评估癌症筛查项目的成本效益。
J Clin Oncol. 2007 Jan 10;25(2):203-8. doi: 10.1200/JCO.2006.07.9202.
6
Diet and cancer: the disconnect between epidemiology and randomized clinical trials.饮食与癌症:流行病学与随机临床试验之间的脱节
Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1366-9. doi: 10.1158/1055-9965.EPI-04-0666.
7
Procedures and methods of benefit assessments for medicines in Germany.德国药品效益评估的程序和方法。
Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.
8
[Methodology and legitimacy of French clinical trials in primary chemoprevention of cancers. The point of view of the National Federation of French cancer centers].[法国癌症一级化学预防临床试验的方法与合理性。法国癌症中心全国联合会的观点]
Bull Cancer. 1995 Jul;82 Suppl 3:232s-236s.
9
The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.全髋关节置换术后住院康复与门诊康复的增量成本效益——一项初步调查的结果
Eur J Med Res. 2008 Jun 24;13(6):267-74.
10
Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report.设计旨在预防或延缓体弱老年人功能衰退和残疾的随机对照试验:一份共识报告。
J Am Geriatr Soc. 2004 Apr;52(4):625-34. doi: 10.1111/j.1532-5415.2004.52174.x.